The Jackson Laboratory is a leading provider of cancer mouse models and in vivo oncology services and a National Cancer Institute designated Cancer Center. Drawing on decades of research experience we provide capabilities around model selection, husbandry and customizable oncology studies to help clients and researchers evaluate novel anti-cancer therapies. Our diverse oncology study protocols range from traditional xenograft services to PDX cancer models and advanced humanized mouse models for immuno-oncology drug development.
Crown Bioscience is a cutting edge translational technology company providing drug discovery and preclinical development services in the areas of oncology, immunology, inflammation, cardiovascular, and metabolic disease. We bring clarity to drug discovery and enable clients around the world to deliver superior clinical candidates. Our premier translational platforms for cancer, inflammation, and metabolic disease help our clients accelerate their new drug development programs.
Studylog’s Animal Study Workflow Software® is designed for biomedical animal research and provides features for the design, planning, execution, analysis, and reporting of animal studies in a standardized, highly efficient manner, while protecting data integrity. Reducing many labs’ study-related labor by half, Studylog automates and streamlines the entire animal study process, making it easier, faster and cheaper, so researchers have more time and resources to get their job done.
Kiyatec is a functional precision oncology company that accurately measures the response of each patient’s live cancer cells to aid in drug development and inform clinical treatment decisions. The company works in partnership with leading biopharmaceutical companies to unlock response dynamics for their pre-clinical investigational drug candidates across most solid tumor types. Kiyatec’s CLIA- certified labs offer clinical testing for high-grade glioma, and is developing assays for use in ovarian, breast, NSCLC, and rare tumors.
Biocytogen is a global one-stop drug discovery solution provider with operations in the US and China. Empowered by its cutting-edge gene editing technologies and state-of-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery. The technical teams in Biocytogen support a comprehensive portfolio of products and services, covering in vivo/in vitro preclinical services, humanized models for immuno-oncology and autoimmune diseases, fully human antibody (via RenMab™ Mouse), therapeutic antibody discovery and development services, CMC/CDMO, and regulatory affairs support. Biocytogen collaborates with more than 70% of top 50 pharmaceutical and numerous biotech start-up companies worldwide.
Certis Oncology Solutions was formed in 2016 with the mission to provide individualized treatment options to cancer patients. Our technology enables oncologists to determine with precision the most effective available therapies to treat each patient’s unique disease. Pharmaceutical companies leverage our expertise in precision oncology to obtain accurate, scientifically relevant data for preclinical decision-making. Findings from our science can dramatically improve lead optimization of new drug candidates, reduce development risk, and expedite path to clinical trials.
For the past 20 years, genOway has aimed to improve the predictability and reliability of preclinical data by designing models of high physiological relevancy to best meet researchers’ needs. With a catalog of humanized immune checkpoint mouse models, and mice featuring the human immune system, genOway possesses a broad set of tools to help decipher the mechanism of action as well as the efficacy and safety of drugs targeting the immune system. Additionally, genOway owns strong intellectual property rights, combining patents and licensing agreements, enabling the company to provide end users the necessary freedom to operate.
Founded in 2007, Scientist.com is the world's leading and fastest-growing marketplace for outsourced scientific services and products. The marketplace saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies. Scientist.com operates private marketplaces for most of the world’s major pharmaceutical companies, over 100 biotechs and the US National Institutes of Health (NIH). The marketplace features 3,800+ registered suppliers offering more than 4,000 research areas across multiple industries.
Champions Oncology is a technology-driven research organization that develops innovative therapeutics against cancer targets, offers groundbreaking research software as a service, and provides end-to-end R&D services to biopharma organizations. Champions Oncology is actively engaged in the transformation of drug discovery through a novel approach of pharmaco-pheno-multiomic integration.
For more information, please visit www.championsoncology.com